We are pleased to announce that Per Hillertz (AstraZeneca) joined the Soft Matter Lab on 26 February 2026 as Adjunct Professor.
Per brings a strong scientific background in structural biology and biophysics, with broad experience across multiple therapy areas, including Oncology, CNS-pain, and respiratory diseases. In his current role as IT Site Lead in Gothenburg and Director of M&A IT at AstraZeneca, he focuses on the development and application of AI technologies within the pharmaceutical value chain.
He also plays an active role in shaping academia–industry collaboration through his involvement in several program boards at Chalmers University of Technology and the University of Gothenburg.
We warmly welcome Per to the lab and look forward to strengthening our collaboration at the interface of soft matter, life sciences, and digital innovation.